These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 18822689

  • 21. Kiss-1 suppresses MMP-9 expression by activating p38 MAP kinase in human stomach cancer.
    Lee KH, Kim JR.
    Oncol Res; 2009; 18(2-3):107-16. PubMed ID: 20066900
    [Abstract] [Full Text] [Related]

  • 22. Involvement of ERK1/2 and p38 MAP kinase in doxorubicin-induced uPA expression in human RC-K8 lymphoma and NCI-H69 small cell lung carcinoma cells.
    Niiya M, Niiya K, Shibakura M, Asaumi N, Yoshida C, Shinagawa K, Teshima T, Ishimaru F, Ikeda K, Tanimoto M.
    Oncology; 2004; 67(3-4):310-9. PubMed ID: 15557793
    [Abstract] [Full Text] [Related]

  • 23. Interleukin-17 modulates myoblast cell migration by inhibiting urokinase type plasminogen activator expression through p38 mitogen-activated protein kinase.
    Kocić J, Santibañez JF, Krstić A, Mojsilović S, Ilić V, Bugarski D.
    Int J Biochem Cell Biol; 2013 Feb; 45(2):464-75. PubMed ID: 23183001
    [Abstract] [Full Text] [Related]

  • 24. Direct evidence that hepatocyte growth factor-induced invasion of hepatocellular carcinoma cells is mediated by urokinase.
    Monvoisin A, Neaud V, De Lédinghen V, Dubuisson L, Balabaud C, Bioulac-Sage P, Desmoulière A, Rosenbaum J.
    J Hepatol; 1999 Mar; 30(3):511-8. PubMed ID: 10190737
    [Abstract] [Full Text] [Related]

  • 25. Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade.
    Lengyel E, Wang H, Gum R, Simon C, Wang Y, Boyd D.
    Oncogene; 1997 May 29; 14(21):2563-73. PubMed ID: 9191056
    [Abstract] [Full Text] [Related]

  • 26. Induction of urokinase-type plasminogen activator, interleukin-8 and early growth response-1 by STI571 through activating mitogen activated protein kinase in human small cell lung cancer cells.
    Yoshida C, Niiya K, Niiya M, Shibakura M, Asaumi N, Tanimoto M.
    Blood Coagul Fibrinolysis; 2007 Jul 29; 18(5):425-33. PubMed ID: 17581316
    [Abstract] [Full Text] [Related]

  • 27. Requirement of the enzymatic and signaling activities of plasmin for phorbol-ester-induced scattering of colon cancer cells.
    Díaz VM, Hurtado M, Kort EJ, Resnati M, Blasi F, Thomson T, Paciucci R.
    Exp Cell Res; 2006 Jul 15; 312(12):2203-13. PubMed ID: 16631161
    [Abstract] [Full Text] [Related]

  • 28. PKC mediates fluctuant ERK-paxillin signaling for hepatocyte growth factor-induced migration of hepatoma cell HepG2.
    Hu CT, Cheng CC, Pan SM, Wu JR, Wu WS.
    Cell Signal; 2013 Jun 15; 25(6):1457-67. PubMed ID: 23524339
    [Abstract] [Full Text] [Related]

  • 29. Urokinase induces stromal cell-derived factor-1 expression in human hepatocellular carcinoma cells.
    Hsu WH, Chen CN, Huang HI, Lai YL, Teng CY, Kuo WH.
    J Cell Physiol; 2012 Feb 15; 227(2):697-704. PubMed ID: 21465475
    [Abstract] [Full Text] [Related]

  • 30. Involvement of down-regulation of Cdk2 activity in hepatocyte growth factor-induced cell cycle arrest at G1 in the human hepatocellular carcinoma cell line HepG2.
    Tsukada Y, Tanaka T, Miyazawa K, Kitamura N.
    J Biochem; 2004 Nov 15; 136(5):701-9. PubMed ID: 15632311
    [Abstract] [Full Text] [Related]

  • 31. Hepatocyte growth factor/c-met signaling in regulating urokinase plasminogen activator in human stomach cancer: A potential therapeutic target for human stomach cancer.
    Lee KH, Choi EY, Hyun MS, Jang BI, Kim TN, Kim SW, Song SK, Kim JH, Kim JR.
    Korean J Intern Med; 2006 Mar 15; 21(1):20-7. PubMed ID: 16646560
    [Abstract] [Full Text] [Related]

  • 32. Dynamic assembly of the urokinase-type plasminogen activator signaling receptor complex determines the mitogenic activity of urokinase-type plasminogen activator.
    Jo M, Thomas KS, Marozkina N, Amin TJ, Silva CM, Parsons SJ, Gonias SL.
    J Biol Chem; 2005 Apr 29; 280(17):17449-57. PubMed ID: 15728176
    [Abstract] [Full Text] [Related]

  • 33. Reactive oxygen species regulate urokinase plasminogen activator expression and cell invasion via mitogen-activated protein kinase pathways after treatment with hepatocyte growth factor in stomach cancer cells.
    Lee KH, Kim SW, Kim JR.
    J Exp Clin Cancer Res; 2009 Jun 04; 28(1):73. PubMed ID: 19497102
    [Abstract] [Full Text] [Related]

  • 34. PKC, p42/44 MAPK and p38 MAPK regulate hepatocyte growth factor secretion from human astrocytoma cells.
    Chattopadhyay N, Tfelt-Hansen J, Brown EM.
    Brain Res Mol Brain Res; 2002 Jun 15; 102(1-2):73-82. PubMed ID: 12191496
    [Abstract] [Full Text] [Related]

  • 35. Hepatocyte growth factor stimulates expression of plasminogen activator inhibitor type 1 and tissue factor in HepG2 cells.
    Wojta J, Nakamura T, Fabry A, Hufnagl P, Beckmann R, McGrath K, Binder BR.
    Blood; 1994 Jul 01; 84(1):151-7. PubMed ID: 7517205
    [Abstract] [Full Text] [Related]

  • 36. Regulation of plasminogen activator inhibitor-1 secretion by urokinase and tissue plasminogen activator in rat epithelioid-type smooth muscle cells.
    Lau HK, Ho J.
    Br J Haematol; 2002 Apr 01; 117(1):151-8. PubMed ID: 11918547
    [Abstract] [Full Text] [Related]

  • 37. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT, Klein PJ, Wentz SC, Zeni A, Menze A, Schmidt CM.
    J Pharmacol Exp Ther; 2009 Jun 01; 329(3):1063-70. PubMed ID: 19258520
    [Abstract] [Full Text] [Related]

  • 38. Hepatocyte growth factor enhances protein phosphatase Cdc25A inhibitor compound 5-induced hepatoma cell growth inhibition via Akt-mediated MAPK pathway.
    Wang Z, Wang M, Carr BI.
    J Cell Physiol; 2005 Jun 01; 203(3):510-9. PubMed ID: 15534860
    [Abstract] [Full Text] [Related]

  • 39. Activation of the urokinase plasminogen activator/urokinase plasminogen activator receptor system and redistribution of E-cadherin are associated with hepatocyte growth factor-induced motility of pancreas tumor cells overexpressing Met.
    Paciucci R, Vilá MR, Adell T, Díaz VM, Torà M, Nakamura T, Real FX.
    Am J Pathol; 1998 Jul 01; 153(1):201-12. PubMed ID: 9665481
    [Abstract] [Full Text] [Related]

  • 40. MEK/ERK-mediated proliferation is negatively regulated by P38 map kinase in the human pancreatic cancer cell line, PANC-1.
    Ding XZ, Adrian TE.
    Biochem Biophys Res Commun; 2001 Mar 30; 282(2):447-53. PubMed ID: 11401480
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.